![Joseph Lyssikatos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Lyssikatos
Fondatore presso
ENLIVEN THERAPEUTICS, INC.
Patrimonio netto: 30 M $ in data 31/05/2026
Profilo
Joseph P.
Lyssikatos is the founder of Enliven Therapeutics, Inc., founded in 2019, where the title held is Chief Scientific Officer since 2024.
Dr. Lyssikatos is also the founder of Enliven Therapeutics, Inc...
Former jobs include Executive Director-Discovery at Stemcentrx, Inc. from 2017 to 2019, Executive Director at AbbVie, Inc., Senior Director at Array BioPharma, Inc., Head-Staff Scientist at Genentech, Inc., Vice President-Medicinal Chemistry & DMPK at Biogen, Inc. from 2014 to 2015, and Denali Fellow at Denali Therapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at The College of William & Mary and a doctorate from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/02/2026 | 758.938 ( 1,25% ) | 30 M $ | 31/05/2026 |
Posizioni attive di Joseph Lyssikatos
| Società | Posizione | Inizio |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Fondatore | 01/06/2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Fondatore | - |
Precedenti posizioni note di Joseph Lyssikatos
| Società | Posizione | Fine |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Corporate Officer/Principal | 01/06/2019 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 01/06/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| ARRAY TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Joseph Lyssikatos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
